Herold Advisors, Inc. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Herold Advisors, Inc. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$33,300,000
+67859.2%
2,0000.0%0.01%
-36.8%
Q3 2021$49,0002,0000.02%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,944,201$27,999,00013.31%
Broadfin Capital, LLC 4,328,303$41,162,0008.50%
GREAT POINT PARTNERS LLC 5,567,348$52,945,0005.24%
FRAZIER MANAGEMENT LLC 2,188,331$20,811,0005.01%
Avoro Capital Advisors LLC 10,530,862$100,148,0004.33%
Prosight Management, LP 917,080$8,721,0003.82%
Perceptive Advisors 12,235,811$116,362,0003.28%
Ghost Tree Capital, LLC 1,150,000$10,937,0002.86%
QVT Financial LP 1,021,361$9,241,0002.32%
Cheyne Capital Management (UK) LLP 186,500$1,774,0001.66%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders